EP0921799A4 - METHOD FOR PRELIMINATING COLON COLUMN TUMORS. - Google Patents

METHOD FOR PRELIMINATING COLON COLUMN TUMORS.

Info

Publication number
EP0921799A4
EP0921799A4 EP97906587A EP97906587A EP0921799A4 EP 0921799 A4 EP0921799 A4 EP 0921799A4 EP 97906587 A EP97906587 A EP 97906587A EP 97906587 A EP97906587 A EP 97906587A EP 0921799 A4 EP0921799 A4 EP 0921799A4
Authority
EP
European Patent Office
Prior art keywords
methods
colon tumors
inhibiting colon
inhibiting
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97906587A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0921799A1 (en
Inventor
Maria L Brandi
Francesco Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0921799A1 publication Critical patent/EP0921799A1/en
Publication of EP0921799A4 publication Critical patent/EP0921799A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
EP97906587A 1996-01-29 1997-01-27 METHOD FOR PRELIMINATING COLON COLUMN TUMORS. Withdrawn EP0921799A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
US10772P 1996-01-29
GB9603150 1996-02-15
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
EP0921799A1 EP0921799A1 (en) 1999-06-16
EP0921799A4 true EP0921799A4 (en) 2002-03-13

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97906587A Withdrawn EP0921799A4 (en) 1996-01-29 1997-01-27 METHOD FOR PRELIMINATING COLON COLUMN TUMORS.

Country Status (19)

Country Link
EP (1) EP0921799A4 (xx)
JP (1) JP2000503994A (xx)
KR (1) KR19990082054A (xx)
CN (1) CN1209745A (xx)
AR (1) AR010978A1 (xx)
AU (1) AU707892B2 (xx)
BR (1) BR9700778A (xx)
CO (1) CO4761062A1 (xx)
CZ (1) CZ235498A3 (xx)
EA (1) EA001104B1 (xx)
ID (1) ID15917A (xx)
IL (1) IL125521A (xx)
MX (1) MX9806036A (xx)
NO (1) NO983451D0 (xx)
NZ (1) NZ331105A (xx)
PL (1) PL328147A1 (xx)
TW (1) TW446560B (xx)
WO (1) WO1997026877A1 (xx)
YU (1) YU2397A (xx)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652004A1 (en) * 1993-10-15 1995-05-10 Eli Lilly And Company Methods for treating resistant neoplasms
EP0664122A1 (en) * 1993-12-21 1995-07-26 Eli Lilly And Company Inhibition of imperfect tissue repair

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652004A1 (en) * 1993-10-15 1995-05-10 Eli Lilly And Company Methods for treating resistant neoplasms
EP0664122A1 (en) * 1993-12-21 1995-07-26 Eli Lilly And Company Inhibition of imperfect tissue repair

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9726877A1 *

Also Published As

Publication number Publication date
EA199800677A1 (ru) 1999-02-25
NO983451L (no) 1998-07-27
EA001104B1 (ru) 2000-10-30
KR19990082054A (ko) 1999-11-15
AU707892B2 (en) 1999-07-22
YU2397A (en) 1999-11-22
ID15917A (id) 1997-08-21
CO4761062A1 (es) 1999-04-27
MX9806036A (es) 1998-11-29
IL125521A0 (en) 1999-03-12
CN1209745A (zh) 1999-03-03
PL328147A1 (en) 1999-01-18
IL125521A (en) 2001-11-25
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
AR010978A1 (es) 2000-08-02
CZ235498A3 (cs) 1999-02-17
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
NO983451D0 (no) 1998-07-27
NZ331105A (en) 2000-06-23
TW446560B (en) 2001-07-21
WO1997026877A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
GB2309723B (en) Improved downhole apparatus
PL327998A1 (en) Novel derivatives of 19-nor-pregnene
ZA98643B (en) Method for inhibiting the growth of cancers
GB2318734B (en) Methods of preventing breast cancer
IL126272A0 (en) Synthesis of indolylmaleimides
IL118574A0 (en) Methods of inhibiting melanoma
IL128376A0 (en) Synthesis of bisindolylmalimides
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
ZA989840B (en) Method of inhibiting metastases of cancer cells
IL115022A0 (en) Methods of inhibiting endometrial cancer
GB9603150D0 (en) Methods of inhibiting colon tumors
ZA97621B (en) Methods of inhibiting colon tumors
IL125521A0 (en) Methods of inhibiting colon tumors
ZA957949B (en) Methods of inhibiting endometrial mitroses
EP0923519A4 (en) PRODUCTION OF HALOALKYNOLS
GB9624800D0 (en) Methods of preventing breast cancer
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
TW358610U (en) Improvement of inter-com
CA78435S (en) Carafe
CA77891S (en) Carafe
CA79176S (en) Carafe
GR2001934Y (en) Set of coins
GB9614101D0 (en) Improved downhole apparatus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020129

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/44 A, 7A 61K 31/40 B, 7A 61K 38/16 B, 7A 61K 31/445 B, 7A 61P 35/00 B

17Q First examination report despatched

Effective date: 20020805

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021217